1-14 of 14 results for subject:"Beta agonists"
Librarians' tools
- Search time
- 0.192 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:"Beta agonists"
- We searched for
- subject_t:"Beta agonists" OR subject_ses:8645
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor the safety of the prescription of short-acting beta agonists.
To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor the safety of the prescription of short-acting beta agonists.
The Medicines and Healthcare products Regulatory Agency is responsible for monitoring the safety of all healthcare products in the United Kingdom, including short-acting beta agonists and oral corticosteroids to treat asthma. They receive information about safety issues from patients and clinicians through the Yellow Card Scheme. They review the product if necessary and take action to minimise risk and maximise benefit to the patients. Decisions about prescribing rest with the doctor or other prescriber who has clinical responsibility for the particular aspect of a patient’s care.
SI 2009/1925. Together with an explanatory memorandum and impact assessment from the Department for Environment, Food and Rural Affairs. Coming into force 10 August 2009.
SI 2009/1925. Together with an explanatory memorandum and impact assessment from the Department for Environment, Food and Rural Affairs. Coming into force 10 August 2009.
SI 2006/755 (Negative instrument). Together with an explanatory memorandum from Department of Environment Food and Rural Affairs. Coming into force 6 April 2006
SI 2006/755 (Negative instrument). Together with an explanatory memorandum from Department of Environment Food and Rural Affairs. Coming into force 6 April 2006
Statement on outcome of the Agriculture Council held in Brussels on 18th and 19th March.
Statement on outcome of the Agriculture Council held in Brussels on 18th and 19th March.
If he will include the group of substances known as anabolic agents with particular reference to beta 2 agonists, salbutamol, clenbuterol, salmeterol and terbutaline, in his proposals to combat the abuse of anabolic steroids; if he plans to extend his recent proposals to combat the misuse of anabolic steroids to...
If he will include the group of substances known as anabolic agents with particular reference to beta 2 agonists, salbutamol, clenbuterol, salmeterol and terbutaline, in his proposals to combat the abuse of anabolic steroids; if he plans to extend his recent proposals to combat the misuse of anabolic steroids to...
What research her Department has conducted into the health effects of prolonged low level consumption of (a) clenbuterol and (b) other beta-agonists.
What research her Department has conducted into the health effects of prolonged low level consumption of (a) clenbuterol and (b) other beta-agonists.
If she will list the countries, in order of frequency, from which meat treated with (a) clenbuterol and (b) other beta-agonists has been imported in each year since 1985.
If she will list the countries, in order of frequency, from which meat treated with (a) clenbuterol and (b) other beta-agonists has been imported in each year since 1985.
If she will comment on her policy towards imports of meat treated with beta-agonists;and if she will make a statement on her policy in respect if beta-agonists.- Inc ref to 230 c562-3W and medicines act veterinary information service newsletter. (In Lib).
If she will comment on her policy towards imports of meat treated with beta-agonists;and if she will make a statement on her policy in respect if beta-agonists.- Inc ref to 230 c562-3W and medicines act veterinary information service newsletter. (In Lib).
Statement on the use of beta-agonists in food animals. - Inc ref to 220 c78-9W.
Statement on the use of beta-agonists in food animals. - Inc ref to 220 c78-9W.
European Community Document 6654/93 relating to the control of residues in meat. Considered by Standing Committee.
European Community Document 6654/93 relating to the control of residues in meat. Considered by Standing Committee.
Salmeterol, a long-acting B2-agonist, guidelines for the treatment of chronic asthma.
Salmeterol, a long-acting B2-agonist, guidelines for the treatment of chronic asthma.
How many post mortem tests are carried out each year on the eyeballs of bovines suspected of treatments with beta agonist drugs. - (No figure given).
How many post mortem tests are carried out each year on the eyeballs of bovines suspected of treatments with beta agonist drugs. - (No figure given).
In which part of an affected animals have residues of beta agonist drugs most frequently been found by official inspections in the past 12 months. - Liver.
In which part of an affected animals have residues of beta agonist drugs most frequently been found by official inspections in the past 12 months. - Liver.
If he has any information relating to adverse effects on human health resulting from the illegal use of Beta Agonists.
If he has any information relating to adverse effects on human health resulting from the illegal use of Beta Agonists.